EDGAR Filing Documents for 9999999995-21-002178

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-21-002178

Accepted

2021-06-02 00:15:39

Documents

Effectiveness Date

2021-06-01

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	600
	Complete submission text file	9999999995-21-002178.txt		2038

Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142

Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075

KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)